A team of researchers have applied a novel blood test that can detect early signs of potentially fatal lung damage in cancer ...

Schrödinger Inc.'s stock soared 14% Tuesday to put in on track for its biggest one-day gain in a year, after the company said it has entered a multi-year collaboration agreement with Swiss pharma ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

The global artificial intelligence (AI) in drug discovery market is projected to reach USD 6.89 billion by 2029 from USD 1.86 ...

AlphaFold 3’s predecessor could predict protein structures The AI model is available for academic purposes only DeepMind ...

Novartis is paying $150 million for a closer look at Schrödinger’s catalog of programs. The Big Pharma will work with Schrödinger to advance some of the computing-enabled R&D shop’s discovery programs ...

Schrödinger today announced a multi-target collaboration and expanded software licensing agreement with Novartis.

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney ...

The market growth is driven by technological progressions such as amalgamation with artificial intelligence and cloud ...

Schrödinger partners with Novartis for advanced computational drug discovery. Q3 revenue rose 10% in software, though total ...

Drug Designing Tools Market. The global drug designing tools market is poised for significant expansion, anticipated to grow ...